Learn about bispecific antibody expression with Horizon's CHOSOURCE CHO-K1 GS knockout platform
Learn from Jay Sinha at Incyte Corp as he presents development of an antibody expression platform using our CHO-K1 GS knockout cell line. Several cell line development systems were studied using a model bispecific antibody. A promising host-vector system has been obtained to pursue further studies. The approaches and challenges experienced with the platform cell line development are here.
- Empowering biotherapeutic production